For example, predicting 1p/19q codeletion status is more relevant in a subset of low-grade gliomas, as it enables to non-invasively distinguish IDH-mut astrocytoma (1p/19q intact) from oligodendroglioma (1p/19q codeleted) [62]. This evidence concerns the gene IDH1 and glioma.